「Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model」の関連論文
-
Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma
-
Annexin A10 is involved in the induction of pancreatic duodenal homeobox-1 in gastric cancer tissue, cells and organoids
-
Annexin A10 is involved in the induction of pancreatic duodenal homeobox-1 in gastric cancer tissue, cells and organoids
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Study of the Effects of Inhibition of Epigenetic Regulators on the Proliferation of Hematological Malignant Tumor Cells
-
Characterization of the Anticancer Activities of Some Natural and Synthetic Compounds: Molecular Targets and Mechanism
-
Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPAEnriched Oral Supplement in Advanced Pancreatic Cancer
-
Design and Functional Evaluation of Drug Delivery System Based on Dendritic Molecules and Gold Nanorods
-
Inactivation of the PD-1-dependent immunoregulation in mice exacerbates contact hypersensitivity resembling immune-related adverse events
-
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
-
Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis
-
Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer
-
A novel cancer immunotherapy using tumor-infiltrating B cells in the APC (min/+) mouse model
-
Finding potential synergistic drugs to reduce chemo-resistance for the treatment of highly malignant tumors in female
-
Gold Nanoparticles Enhance the Tumor Growth-Suppressing Effects of Cetuximab and Radiotherapy in Head and Neck Cancer In Vitro and In Vivo
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
Evaluating the effect of lenvatinib on sorafenib-resistant hepatocellular carcinoma cells
-
Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest
-
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
Editorial: Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy
-
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
-
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
-
JNK and Yorkie drive tumor malignancy by inducing L-amino acid transporter 1 in Drosophila
-
Efficacious Combination Drug Treatment for Colorectal Cancer that Overcomes Resistance to KRAS G12C Inhibitors
-
Results of the guideline-based treatment for pemphigus : a single-centre experience with 84 cases (本文)
-
Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma
-
Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells
-
Development of a novel cancer therapy with a ferroptosis inducer and radiation, and a prediction method for therapeutic effects targeting ferroptosis
-
BMP and activin membrane-bound inhibitor (BAMBI) regulates mesothelioma cell proliferation and clinical outcome
-
BMP and activin membrane-bound inhibitor (BAMBI) regulates mesothelioma cell proliferation and clinical outcome
-
Functional analysis of mitochondria-mediated ovarian carcinoma immune-reactive antigen domain 2 in lung adenocarcinoma
-
Local hyperthermia with built-in endoscopy for radioresistant cervical cancer: a case series
-
The Interaction between Cancer-associated Fibroblasts and Cancer Cells Enhances Bcl-xL and Mcl-1 in Colorectal Cancer
-
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
-
Preclinical Evaluation of Lymph Node Targeted Therapy in Mouse Models of Cancer
-
Clinical efficacy of the combined treatment of anti-PD-L1 rat-bovine chimeric antibody with a COX-2 inhibitor in calves infected with Mycoplasma bovis
-
Suppression of malignant rhabdoid tumors through Chb-M′-mediated RUNX1 inhibition
-
Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase
-
Therapeutic Drug Monitoring of Antibody Drugs
-
Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
-
大腸癌におけるアポトーシス、ネクロトーシス、オートファジー:腫瘍の病理学的悪性度とp53タンパク発現状態との関連性について
-
Lusutrombopag effectively promotes the growth and differentiation of megakaryocytic cells from patients with myelodysplastic syndrome
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
-
Identification and characterization of slow‑cycling cells in Ewing sarcoma
-
Cell therapy for Parkinson's disease with induced pluripotent stem cells
-
Targeted epigenetic induction of mitochondrial biogenesis enhances antitumor immunity in mouse model
-
Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans (本文)